Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-03-15Clinical Trial Update: Safety and Efficacy Study of PLX3397 in Adults With Relapsed or Refractory Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating PLX3397 for safety and efficacy in adults with relapsed or refractory Hodgkin Lymphoma has completed; results poste…
-
CLINICAL_TRIALS trial_result · 2013-03-14Clinical Trial Update: Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies [Phase 3]
Phase 3 study evaluating methotrexate or pentostatin for graft-versus-host disease prophylaxis in risk-adapted allogeneic bone marrow transp…
-
CLINICAL_TRIALS trial_result · 2013-03-06Clinical Trial Update: Prognosis of Patients With Relapsed/Refractory Hodgkin Lymphoma Treated With IGEV Induction Therapy Before HDCT With AHSCT
This clinical trial update reports prognostic outcomes for patients with relapsed or refractory Hodgkin lymphoma treated with IGEV induction…
-
CLINICAL_TRIALS trial_result · 2013-03-05Clinical Trial Update: IGEV Followed by Autologous Transplantation for Refractory or Relapsed Hodgkin Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating the IGEV chemotherapy regimen followed by autologous stem cell transplantation in patients with refracto…
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Aminocamptothecin in Treating Patients With Refractory or Recurrent Hodgkin's Disease or Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 trial evaluating aminocamptothecin in patients with refractory or recurrent Hodgkin lymphoma or non-Hodgkin lymphoma has been comp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma [Phase 1]
This Phase 1 trial evaluated the Hsp90 inhibitor tanespimycin (17-AAG) in patients with advanced epithelial cancers, malignant lymphomas, or…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction [Phase 1]
This clinical trial update summarizes a Phase 1 study of Imatinib Mesylate in patients with advanced cancer and liver dysfunction, which has…
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: S0410 Tandem Stem Cell Transplantation in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma [Phase 2]
Phase 2 study evaluating tandem stem cell transplantation in patients with progressive or recurrent Hodgkin lymphoma; results were posted af…
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Study of a-Interferon With Adriamycin, Bleomycin, Velban, and Dacarbazine (ABVD) With Hodgkin's Disease [Phase 2]
Phase 2 clinical trial evaluating the addition of alpha-interferon to the ABVD chemotherapy regimen for Hodgkin lymphoma; the study complete…
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas [Phase 1]
Phase 1 clinical trial evaluating 17-DMAG (alvespimycin), an HSP90 inhibitor, in patients with metastatic or unresectable solid tumors or ly…
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: Oblimersen and Gemcitabine in Treating Patients With Advanced Solid Tumor or Lymphoma [Phase 1]
An update on a Phase 1 trial of oblimersen in combination with gemcitabine for patients with advanced solid tumors or lymphoma, which has be…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: MS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or Lymphomas [Phase 1]
This Phase 1 trial evaluated entinostat (MS-275) plus isotretinoin in adults with metastatic or advanced solid tumors or various lymphomas; …
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: CCI-779 in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 study of temsirolimus (CCI-779) in relapsed or refractory chronic lymphocytic leukemia has been terminated. The study also involved …
-
CLINICAL_TRIALS trial_result · 2013-01-14Clinical Trial Update: SB-715992 in Treating Patients With Metastatic or Unresectable Solid Tumors or Hodgkin's or Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial of SB-715992 in patients with metastatic or unresectable solid tumors and various Hodgkin's and non-Hodgkin's lymphomas has be…
-
CLINICAL_TRIALS trial_result · 2013-01-09Clinical Trial Update: Prevention of Ovarian Function Damage by a GnRH Analogue During Chemotherapy in Hodgkin Lymphoma Patients [NA]
This completed clinical trial evaluated whether giving a GnRH analogue during chemotherapy can prevent ovarian function damage in Hodgkin ly…
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: Gemcitabine, Cisplatin, and Dexamethasone in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating gemcitabine, cisplatin, and dexamethasone in patients with relapsed or refractory Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2012-12-20Clinical Trial Update: Pulmonary Function in Patients With Hodgkin's Disease Receiving Bleomycin-Based Chemotherapy
This update reports on a completed clinical trial evaluating pulmonary function in Hodgkin lymphoma patients treated with bleomycin-based ch…
-
CLINICAL_TRIALS trial_result · 2012-12-18Clinical Trial Update: Positron Emission Tomography(PET) in Lymphoma Assessment [NA]
Clinical trial update on PET imaging for Hodgkin lymphoma and Non-Hodgkin lymphoma assessment reports the study status as completed.
-
CLINICAL_TRIALS trial_result · 2012-12-07Clinical Trial Update: Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor [Phase 2]
Phase 2 study evaluating parathyroid hormone after sequential cord blood transplantation from an unrelated donor; the trial was terminated a…
-
CLINICAL_TRIALS trial_result · 2012-12-06Clinical Trial Update: Phase 1 Study of MDX-1401 in Patients With CD30-positive Refractory/Relapsed Hodgkin's Lymphoma [Phase 1]
A Phase 1 study evaluating MDX-1401 in patients with CD30-positive relapsed or refractory Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-11-12Clinical Trial Update: High Dose Chemotherapy Followed By PBSC Rescue for HD [NA]
This is a completed clinical trial from Stanford University evaluating high-dose chemotherapy followed by peripheral blood stem cell rescue …
-
CLINICAL_TRIALS trial_result · 2012-11-06Clinical Trial Update: Giving Gene Marked EBV Specific T-Cells to Patients Receiving a BMT for Relapsed EBV-Positive Hodgkin Disease [Phase 1]
A Phase 1 clinical trial update describes giving gene-marked EBV-specific T-cells to patients receiving a bone marrow transplant for relapse…
-
CLINICAL_TRIALS trial_result · 2012-10-04Clinical Trial Update: Combination Chemotherapy With or Without Amifostine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Disease Undergoing Stem Cell Transplantation [Phase 2]
This Phase 2 trial evaluates adding amifostine to chemotherapy versus chemotherapy alone in patients with recurrent or refractory non-Hodgki…
-
CLINICAL_TRIALS trial_result · 2012-09-19Clinical Trial Update: Vorinostat in Treating Patients With Relapsed or Refractory Advanced Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial of vorinostat in adults with relapsed or refractory advanced Hodgkin lymphoma has completed, with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2012-09-18Clinical Trial Update: Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating pralatrexate and gemcitabine with B12 and folic acid in relapsed/refractory lymphoproliferative malignan…